Fennec Pharmaceuticals redeems all convertible notes, now debt-free

FENNEC PHARMACEUTICALS INC.

Redeemed all remaining Petrichor convertible notes for $21.73M (principal $19.48M, accrued interest $305k, redemption fee $1.95M).
Used proceeds from underwritten public offering and private placement closed Nov 17-18, 2025.
Company has no outstanding debt after the redemption.
Notes previously bore interest at prime rate plus 4.5% (floor 3.5%) and had maturity Aug 19, 2027.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.